{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:32:29Z","timestamp":1788802349272,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertrophic spinal pachymeningitis (HSP) and retroperitoneal fibrosis (RPF) are rare inflammatory disorders, often associated with immunoglobulin G4-related disease (IgG4-RD). This case underscores the diagnostic intricacies and therapeutic challenges in a patient with overlapping neurological and systemic manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 34-year-old female presented with concurrent RPF and HSP leading to urinary tract obstruction and progressive spinal cord compression. The patient initially presented with lower limb weakness and urinary dysfunction, followed by acute paraparesis after a fall. Despite normal serum IgG4 levels, a pathological examination of the dural biopsy confirmed the diagnosis of IgG4-RD. Following a multidisciplinary treatment approach that included surgical decompression, glucocorticoids, immunomodulators and antifibrotic therapy, the patient achieved a favorable clinical outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Literature review<\/jats:title>\n                    <jats:p>A systematic review of 22 cases involving patients with HSP revealed that key manifestations included localized pain, motor deficits, sensory abnormalities and autonomic dysfunction. The majority of patients (82%, 18\/22) exhibited isolated HSP, with a predominance of thoracic spine involvement. Pathological examination demonstrated lymphoplasmacytic infiltration in all cases (100%, 22\/22), with 95% (19\/20) meeting the criteria for IgG4-positive plasma cells; storiform fibrosis and obliterative phlebitis were observed in 56% (5\/9) of cases. Treatment strategies primarily involved surgical decompression (95%, 21\/22) and glucocorticoids (95%, 21\/22), with 52% (11\/21) receiving additional immunosuppressive agents. Clinical outcomes showed complete neurological recovery in 19% (4\/21), partial recovery in 71% (15\/21). Recurrence was documented in 17% (3\/18) of patients with available follow-up data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This rare case underscores the importance of integrating clinical, radiological, and histopathological findings to diagnose HSP and RPF, particularly in the context of IgG4-RD. Early multidisciplinary management is critical to improving outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1619756","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:45:24Z","timestamp":1756446324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["IgG4-related disease presenting with retroperitoneal fibrosis and hypertrophic spinal pachymeningitis: a rare case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jianchun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60720-0","article-title":"IgG4-related disease","volume":"385","author":"Kamisawa","year":"2015","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00299-0","article-title":"Fibrotic phenotype of IgG4-related disease","volume":"6","author":"Lanzillotta","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X14546160","article-title":"Retroperitoneal fibrosis","volume":"19","author":"Tzou","year":"2014","journal-title":"Vasc Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200229","article-title":"Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy","volume":"22","author":"De Socio","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0245601","DOI":"10.1371\/journal.pone.0245601","article-title":"Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis","volume":"16","author":"Wang","year":"2021","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181abdfc2","article-title":"IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease","volume":"33","author":"Chan","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jns.2014.10.012","article-title":"Hypertrophic spinal pachymeningitis: idiopathic vs. IgG4-related","volume":"347","author":"Ezzeldin","year":"2014","journal-title":"J Neurol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001872","article-title":"FDG PET\/CT in immunoglobulin G4-related spinal hypertrophic pachymeningitis","volume":"42","author":"Zhao","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2017.07.012","article-title":"IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity","volume":"46","author":"Maher","year":"2017","journal-title":"Clin Imaging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1971400917698173","article-title":"Neurological involvement of IgG4-related disease: description of a case and review of the literature","volume":"31","author":"Varrassi","year":"2018","journal-title":"Neuroradiol J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/sni.sni_156_18","article-title":"Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression","volume":"9","author":"Winkel","year":"2018","journal-title":"Surg Neurol Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.wneu.2019.06.130","article-title":"Spinal igG4-related hypertrophic pachymeningitis with spinal cord compression: case report and literature review","volume":"130","author":"Slade","year":"2019","journal-title":"World Neurosurg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577325","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report","volume":"347","author":"Li","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.07.227","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis of the spine: A case report and systematic review of the literature","volume":"143","author":"Sbeih","year":"2020","journal-title":"World Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106342","article-title":"Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case","volume":"200","author":"Elmaci","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-021-01114-1","article-title":"Freiburg neuropathology case conference: A 56-year-old man presenting with progressive gait disorder, neck pain, and lower cranial nerve palsy","volume":"31","author":"Sankowski","year":"2021","journal-title":"Clin Neuroradiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.349589","article-title":"IgG4-related pachymeningitis as a cause of spinal epidural compression: can intraoperative frozen sections predict the underlying pathology","volume":"70","author":"Karthigeyan","year":"2022","journal-title":"Neurol India"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.349607","article-title":"Recurrent igG4-related meningeal disease of the cervicothoracic spine: A case report and review of the literature","volume":"70","author":"Kramer","year":"2022","journal-title":"Neurol India"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.986694","article-title":"IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review","volume":"13","author":"Xia","year":"2022","journal-title":"Front Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e23.00024","DOI":"10.2106\/JBJS.CC.23.00024","article-title":"IgG4-related spinal hypertrophic pachymeningitis with neurological deficit: A report of 2 cases","volume":"13","author":"Tanaviriyachai","year":"2023","journal-title":"JBJS Case Connect"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e60546","DOI":"10.7759\/cureus.60546","article-title":"Risk of misdiagnosis in spinal hypertrophic pachymeningitis: A report of two cases","volume":"16","author":"Kageyama","year":"2024","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bjrcr\/uaae022","article-title":"A case of IgG4-related disease manifesting as a spinal epidural mass","volume":"10","author":"Chau","year":"2024","journal-title":"BJR Case Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-024-00343-2","article-title":"Intrathecal IgG4 synthesis in IgG4 related spinal hypertrophic pachymeningitis: a case report","volume":"6","author":"Feldmann","year":"2024","journal-title":"Neurol Res Pract"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2024.103325","article-title":"Cervical myelopathy caused by IgG4-related hypertrophic spinal pachymeningitis: Case report and a descriptive review of the literature","volume":"4","author":"Parlak","year":"2024","journal-title":"Brain Spine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i32.6551","article-title":"Immunoglobulin G4-related spinal pachymeningitis: A case report","volume":"12","author":"Chae","year":"2024","journal-title":"World J Clin Cases"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100047","article-title":"Immunological mechanism of IgG4-related disease","volume":"3","author":"Liu","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30471-4","article-title":"IgG4-related disease of the central and peripheral nervous systems","volume":"17","author":"AbdelRazek","year":"2018","journal-title":"Lancet Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283412f4a","article-title":"Pathogenesis of igG4-related disease","volume":"23","author":"Zen","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease","volume":"145","author":"Della-Torre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/25785826.2024.2407224","article-title":"The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics","volume":"48","author":"Akiyama","year":"2025","journal-title":"Immunol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.085613","article-title":"Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders","volume":"64","author":"Strehl","year":"2011","journal-title":"J Clin Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa221","article-title":"Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes","volume":"59","author":"Lanzillotta","year":"2020","journal-title":"Rheumatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3104-x","article-title":"IgG4-related spinal pachymeningitis","volume":"35","author":"Lu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.10.008","article-title":"Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis","volume":"266","author":"Della-Torre","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2012.11.010","article-title":"Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis","volume":"24","author":"van Bommel","year":"2013","journal-title":"Eur J Intern Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.01.004","article-title":"Histopathologic analysis of tamoxifen on epidural fibrosis","volume":"111","author":"Ozturk","year":"2018","journal-title":"World Neurosurg"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:45:25Z","timestamp":1756446325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1619756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2025.1619756"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1619756","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"article-number":"1619756"}}